Dr. Vasyl Warvariv, MD

Dr. Warvariv practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Warvariv's NPI, 1033201710, was assigned on September 29, 2006. Dr. Warvariv graduated from The Johns Hopkins University School of Medicine in 1981. Dr. Warvariv's California license number on file is G55115.

Dr. Warvariv's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Warvariv's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Warvariv to 1 more hospital, named with a free account. Dr. Warvariv's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Warvariv practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Warvariv's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Warvariv is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Warvariv's licenses on file in 2 states: California and Pennsylvania.

CMS data shows 82 Medicare services from Dr. Warvariv across 2 procedure codes in 2024, for 39 Medicare patients. Medicare paid $5,164 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 39 Medicare patients who saw Dr. Warvariv in 2024. The largest group is under 65, with 20 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 64% are also on Medicaid. Their average risk score is 7.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Warvariv's median patient age at 60, with 33% women.

In 2024, Dr. Warvariv wrote 233 Medicare Part D claims for 31 patients. 90% of them were for generic drugs. CMS names the drug for 183 of them, across 5 drugs with 11 or more claims each, at $27,695 in total drug cost. In 2023, CMS named 205 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Warvariv for performance year 2024, reported as part of a group.

Dmand AI links 2 papers to Dr. Warvariv. The most frequent topics are Cyclosporins and Kidney Transplantation. Dr. Warvariv's most frequent co-authors are William Bry, MD and Gregory D. Linkowski, MD.

Dr. Warvariv graduated from The Johns Hopkins University School of Medicine in 1981.

Dr. Warvariv is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.